BRPI0917391A2 - peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo - Google Patents

peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo

Info

Publication number
BRPI0917391A2
BRPI0917391A2 BRPI0917391A BRPI0917391A BRPI0917391A2 BR PI0917391 A2 BRPI0917391 A2 BR PI0917391A2 BR PI0917391 A BRPI0917391 A BR PI0917391A BR PI0917391 A BRPI0917391 A BR PI0917391A BR PI0917391 A2 BRPI0917391 A2 BR PI0917391A2
Authority
BR
Brazil
Prior art keywords
hig2
same
epitope peptide
vaccines containing
urlc10
Prior art date
Application number
BRPI0917391A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ohsawa
Sachiko Yoshimura
Takuya Tsunoda
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of BRPI0917391A2 publication Critical patent/BRPI0917391A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0917391A 2008-08-19 2009-08-14 peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo BRPI0917391A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8997208P 2008-08-19 2008-08-19
PCT/JP2009/003897 WO2010021112A1 (en) 2008-08-19 2009-08-14 Hig2 and urlc10 epitope peptide and vaccines containing the same

Publications (1)

Publication Number Publication Date
BRPI0917391A2 true BRPI0917391A2 (pt) 2015-12-01

Family

ID=41707003

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917391A BRPI0917391A2 (pt) 2008-08-19 2009-08-14 peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo

Country Status (16)

Country Link
US (1) US9119800B2 (cg-RX-API-DMAC7.html)
EP (1) EP2328600B9 (cg-RX-API-DMAC7.html)
JP (1) JP5633025B2 (cg-RX-API-DMAC7.html)
KR (1) KR101713581B1 (cg-RX-API-DMAC7.html)
CN (2) CN104958753B (cg-RX-API-DMAC7.html)
AU (1) AU2009283763B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0917391A2 (cg-RX-API-DMAC7.html)
CA (1) CA2734467C (cg-RX-API-DMAC7.html)
DK (1) DK2328600T3 (cg-RX-API-DMAC7.html)
ES (1) ES2566011T3 (cg-RX-API-DMAC7.html)
IL (1) IL211117A (cg-RX-API-DMAC7.html)
MX (2) MX337756B (cg-RX-API-DMAC7.html)
RU (1) RU2529373C2 (cg-RX-API-DMAC7.html)
SG (2) SG10201610206VA (cg-RX-API-DMAC7.html)
TW (2) TWI543767B (cg-RX-API-DMAC7.html)
WO (1) WO2010021112A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
EP2640842B1 (en) * 2010-11-17 2018-05-30 Aduro Biotech, Inc. Methods and compositions for inducing an immune response to egfrviii
WO2014010232A1 (en) 2012-07-10 2014-01-16 Oncotherapy Science, Inc. Ly6k epitope peptides for th1 cells and vaccines containing the same
CN106795204B (zh) * 2014-08-04 2021-09-28 肿瘤疗法科学股份有限公司 Urlc10衍生的肽和含有它们的疫苗
PL3335725T3 (pl) 2015-08-10 2024-07-22 Toray Industries, Inc. Epitopy PDS5A jako induktory odporności
CN112961213A (zh) 2015-08-12 2021-06-15 肿瘤疗法科学股份有限公司 Depdc1衍生的肽和包含它们的疫苗
JP7538601B2 (ja) 2017-04-26 2024-08-22 ユーリカ セラピューティックス， インコーポレイテッド キメラ活性化受容体及びキメラ刺激受容体を発現する細胞並びにその使用
DK3538645T3 (da) 2017-06-20 2021-04-19 Inst Curie Immunceller der mangler suv39h1
CN115300609A (zh) * 2021-05-08 2022-11-08 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070014787A1 (en) 1998-07-15 2007-01-18 Human Genome Sciences, Inc. 71 human secreted proteins
WO2001011044A1 (fr) * 1999-08-05 2001-02-15 Kyogo Itoh Antigene de tumeur
AU7748200A (en) 1999-09-30 2001-04-30 Varian Associates, Inc. Hypoxia-related human genes, proteins, and uses thereof
MXPA03003151A (es) 2000-10-13 2003-08-19 Eos Biotechnology Inc Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata.
US20030232350A1 (en) 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
US20070015271A1 (en) 2002-04-04 2007-01-18 Rosen Craig A Human secreted proteins
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CN1882698B (zh) * 2003-08-20 2011-05-25 肿瘤疗法科学股份有限公司 低氧可诱导的蛋白2(hig2)作为新的治疗肾细胞癌(rcc)的潜在标靶
CA2570392A1 (en) 2004-06-21 2005-12-29 Green Peptide Co., Ltd. Peptide vaccine for cancer therapy
EP2311983A1 (en) 2005-02-10 2011-04-20 Oncotherapy Science, Inc. Method of treating bladder cancer using siRNA
ES2459466T3 (es) * 2005-02-25 2014-05-09 Oncotherapy Science, Inc. Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1
CA2599875A1 (en) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
WO2007013575A2 (en) 2005-07-28 2007-02-01 Oncotherapy Science, Inc. Method for diagnosing and treating renal cell carcinoma
US20080306243A1 (en) 2005-09-07 2008-12-11 Nec Corporation Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide
JP4840858B2 (ja) * 2006-03-16 2011-12-21 学校法人慶應義塾 癌ワクチン
CN101472943B (zh) 2006-06-16 2013-07-17 肿瘤疗法·科学股份有限公司 来自sparc的癌排斥抗原肽以及含有该肽的药物
TWI494319B (zh) * 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
WO2009016691A1 (en) 2007-07-30 2009-02-05 Oncotherapy Science, Inc. Cancer associated gene ly6k
TW201000115A (en) 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
IL211117A0 (en) 2011-04-28
AU2009283763A2 (en) 2011-07-07
MX355054B (es) 2018-04-03
EP2328600A4 (en) 2013-03-06
CN102186491B (zh) 2015-06-10
AU2009283763B2 (en) 2014-06-19
US9119800B2 (en) 2015-09-01
IL211117A (en) 2017-03-30
CA2734467A1 (en) 2010-02-25
SG10201610206VA (en) 2017-01-27
MX337756B (es) 2016-03-17
CN104958753A (zh) 2015-10-07
RU2011110376A (ru) 2012-09-27
DK2328600T3 (en) 2016-03-29
MX2011001883A (es) 2011-03-29
CA2734467C (en) 2017-10-03
WO2010021112A1 (en) 2010-02-25
EP2328600A1 (en) 2011-06-08
TWI580431B (zh) 2017-05-01
US20110243973A1 (en) 2011-10-06
EP2328600B9 (en) 2016-07-13
AU2009283763A1 (en) 2010-02-25
KR20110045052A (ko) 2011-05-03
EP2328600B1 (en) 2016-01-27
KR101713581B1 (ko) 2017-03-08
TWI543767B (zh) 2016-08-01
CN104958753B (zh) 2018-09-25
TW201500055A (zh) 2015-01-01
JP5633025B2 (ja) 2014-12-03
HK1157204A1 (zh) 2012-06-29
CN102186491A (zh) 2011-09-14
ES2566011T3 (es) 2016-04-08
RU2529373C2 (ru) 2014-09-27
JP2012500184A (ja) 2012-01-05
TW201019952A (en) 2010-06-01
SG193806A1 (en) 2013-10-30

Similar Documents

Publication Publication Date Title
IL211131A0 (en) Inhbb epitope and vaccines containing the same
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
BRPI0917391A2 (pt) peptídeo de epítodo de hig2 e urlc10 e vacinas contendo o mesmo
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
IL209869A0 (en) Iqgap3 epitope peptides and vaccines containing the same
IL229926A (en) 3neil peptides and vaccines containing them
IL209870A0 (en) Mybl2 epitope peptides and vaccines containing the same
IL232461A0 (en) Melk epitope peptides and vaccines containing the same
BRPI0919766A2 (pt) peptídeo de epítopo de rab6kifl/kif20a e vacinas contendo o mesmo
IL213318A0 (en) C1orf59 peptides and vaccines including the same
IL214453A0 (en) Vangli peptides and vaccines including the same
ZA201207342B (en) Ect2 peptides and vaccines including the same
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
BRPI0922844A2 (pt) peptídeos de epítopo de wdrpuh e vacinas contendo os mesmos
TH0901004695A (th) Rab6kifl/kif20a อิพิโทป เปปไทด์ และ วัคซีนที่ ประกอบด้วยสิ่งเดียวกันนั้น
HK1162528A (en) Wdrpuh epitope peptides and vaccines containing the same
HK1155755A (en) Iqgap3 epitope peptides and vaccines containing the same
HK1157815A (en) Inhbb epitope peptides and vaccines containing the same

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B10A Cessation: cessation confirmed

Free format text: HOMOLOGADA A DESISTENCIA DO PEDIDO SOLICITADA ATRAVES DA PETICAO NO 870190012592 DE 07/02/2019.